1. Editor's page

   EditorialNotes Pages: 195 - 195

2. The development of tamoxifen for breast cancer therapy: A tribute to the late Arthur L. Walpole

   • V. Craig Jordan

   Review Pages: 197 - 209

3. Secreted growth factors from estrogen receptor-negative human breast cancer do not support growth of estrogen receptor-positive breast cancer in the nude mouse model

   • C. Kent Osborne
   • Connie R. Ross
   • Libbey J. Kitten

   Report Pages: 211 - 219

4. Cell cycle synchronization induced by tamoxifen and 17β-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine

   • S. Bruno
   • A. Di Vinci
   • W. Giaretti

   Report Pages: 221 - 229

5. Role of polyamines in the growth of hormone-responsive experimental breast cancerin vivo

   • Andrea Manni
   • Betty Badger
   • S. Rafeeq Ahmed

   Report Pages: 231 - 240

6. Morphometric evaluation of microvessels surrounding hyperplastic and neoplastic mammary lesions

   • Antonio Ottinetti
   • Anna Sapino

   Report Pages: 241 - 248

7. Tests for detecting recurrent disease in the follow-up of patients with breast cancer

   • J. L. Mansi
   • H. M. Earl
   • R. C. Coombes

   Report Pages: 249 - 254

8. Association of breast fluid coloration with age, ethnicity, and cigarette smoking

   • Nicholas L. Petrakis
   • Rei Miike
   • Betty Chang-Lee

   Report Pages: 255 - 262

9. Breast cancer family history as a risk factor for early onset breast cancer

   • Henry T. Lynch
   • Patrice Watson
   • Jane Lynch

   Report Pages: 263 - 267

10. Cisplatin and 5-fluorouracil in refractory breast cancer patients: A phase II study

    • Domenico Amoroso
    • Paolo Pronzato
    • Riccardo Rosso

    Brief communication Pages: 269 - 271

11. Markers in breast cancer: Does CEA add to the detection by CA 15.3?

    • J. C. Delarue
    • H. Mouriesse
    • F. May-Levin

    Brief communication Pages: 273 - 276

12. Announcement

    Announcement Pages: 277 - 280